佛慈制药
(002644)
| 流通市值：36.82亿 | | | 总市值：36.82亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 365,338,610.71 | 406,040,604.7 | 305,731,854.04 | 336,079,651.82 |
| 应收票据及应收账款 | 359,772,626.14 | 285,487,599.46 | 475,512,840.65 | 413,915,594.18 |
| 应收账款 | 359,772,626.14 | 285,487,599.46 | 475,512,840.65 | 413,915,594.18 |
| 应收款项融资 | 78,731,929.42 | 97,163,546.77 | 10,842,150.6 | 39,001,909.55 |
| 预付款项 | 13,219,186.61 | 17,062,096.92 | 39,822,448.2 | 53,186,708.06 |
| 其他应收款合计 | 36,630,896.16 | 42,098,745.16 | 41,952,853.58 | 42,462,250.92 |
| 存货 | 379,869,353.52 | 369,720,187.96 | 379,711,659.83 | 396,819,464.22 |
| 其他流动资产 | 19,282,332.69 | 21,296,541.87 | 17,505,830.08 | 15,960,048.91 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,252,844,935.25 | 1,238,869,322.84 | 1,271,079,636.98 | 1,297,425,627.66 |
| 非流动资产: | | | | |
| 长期股权投资 | 61,493,830.98 | 64,103,030.98 | 69,862,070.23 | 70,113,938.31 |
| 投资性房地产 | 8,012,393.43 | 8,116,873.48 | 8,163,756.01 | 8,271,199.3 |
| 固定资产 | 1,041,356,917 | 1,056,198,751.95 | 1,035,322,545.71 | 1,047,260,622.81 |
| 在建工程 | 3,885,240.75 | 3,299,498.18 | 8,283,762.09 | 10,415,246.67 |
| 使用权资产 | 2,027,045.2 | 2,337,536.94 | 690,080.76 | 861,837.45 |
| 无形资产 | 79,317,596.04 | 79,551,495.79 | 80,501,316.34 | 81,291,539.93 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 4,472,232.85 | 4,472,232.85 |
| 长期待摊费用 | 10,645,151 | 7,654,824.09 | 9,751,364.61 | 9,801,836 |
| 递延所得税资产 | 51,404,898.7 | 53,648,272.25 | 49,930,275.58 | 50,431,215.15 |
| 其他非流动资产 | 7,504,750.72 | 5,313,021.02 | 24,062,353.25 | 17,356,346.27 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,274,657,410.66 | 1,289,232,891.52 | 1,291,039,757.43 | 1,300,276,014.74 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,527,502,345.91 | 2,528,102,214.36 | 2,562,119,394.41 | 2,597,701,642.4 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 304,539,339.84 | 310,372,778.5 | 367,784,554.73 | 355,955,126.41 |
| 其中：应付票据 | 5,400,000 | 27,434,000 | 24,031,804.7 | 4,597,604.7 |
| 应付账款 | 299,139,339.84 | 282,938,778.5 | 343,752,750.03 | 351,357,521.71 |
| 合同负债 | 44,366,471.04 | 47,017,257.29 | 29,893,209.83 | 35,877,175.61 |
| 应付职工薪酬 | 3,382,624.18 | 4,185,589.19 | 1,903,750.06 | 1,852,669.86 |
| 应交税费 | 35,076,676.13 | 35,125,433.42 | 31,561,072.13 | 29,185,996.05 |
| 其他应付款合计 | 44,538,986.23 | 40,458,857.09 | 34,578,386.86 | 75,760,432.08 |
| 一年内到期的非流动负债 | 14,731,850.46 | 14,685,728.18 | 15,238,160.01 | 14,082,207.63 |
| 其他流动负债 | 5,767,641.24 | 5,841,866.89 | 3,607,925.42 | 4,179,692.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 462,403,589.12 | 467,687,510.56 | 494,567,059.04 | 526,893,299.84 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 5,660,000 | 5,660,000 |
| 租赁负债 | 1,391,006.2 | 1,345,791.72 | 148,981.86 | 347,707.28 |
| 长期应付款 | 13,200,000 | 26,600,000 | 26,600,000 | 26,600,000 |
| 递延收益 | 261,274,351.99 | 260,964,150.35 | 265,194,259.93 | 269,512,846.18 |
| 递延所得税负债 | 2,161,887.94 | 3,074,827.24 | 1,935,640.94 | 2,856,672.09 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 278,027,246.13 | 291,984,769.31 | 299,538,882.73 | 304,977,225.55 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 740,430,835.25 | 759,672,279.87 | 794,105,941.77 | 831,870,525.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 337,378,624.27 | 337,378,624.27 | 343,511,317.07 | 343,511,317.07 |
| 其他综合收益 | -58,737.67 | -58,737.67 | 94,654.53 | 99,745.75 |
| 专项储备 | 1,268,476.58 | 1,268,476.58 | 1,523,800.35 | 1,523,800.35 |
| 盈余公积 | 119,928,027.47 | 119,928,027.47 | 117,961,914.32 | 117,961,914.32 |
| 未分配利润 | 794,584,641.39 | 776,197,417.12 | 775,248,551.74 | 773,182,620.83 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,763,758,032.04 | 1,745,370,807.77 | 1,748,997,238.01 | 1,746,936,398.32 |
| 少数股东权益 | 23,313,478.62 | 23,059,126.72 | 19,016,214.63 | 18,894,718.69 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,787,071,510.66 | 1,768,429,934.49 | 1,768,013,452.64 | 1,765,831,117.01 |
| 负债和股东权益合计 | 2,527,502,345.91 | 2,528,102,214.36 | 2,562,119,394.41 | 2,597,701,642.4 |
| 公告日期 | 2024-04-10 | 2024-04-10 | 2023-10-31 | 2023-08-03 |
| 审计意见(境内) | | 标准无保留意见 | | |